Husam H. Balkhy
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endoscopy | 31 | 2022 | 320 | 11.820 |
Why?
| Coronary Artery Disease | 22 | 2022 | 367 | 10.630 |
Why?
| Coronary Artery Bypass | 29 | 2022 | 215 | 10.210 |
Why?
| Coronary Artery Bypass, Off-Pump | 14 | 2022 | 37 | 9.030 |
Why?
| Cardiac Surgical Procedures | 13 | 2021 | 467 | 5.360 |
Why?
| Robotics | 12 | 2022 | 251 | 5.320 |
Why?
| Coronary Vessels | 7 | 2020 | 187 | 4.100 |
Why?
| Mammary Arteries | 9 | 2022 | 24 | 3.680 |
Why?
| Heart Valve Prosthesis Implantation | 6 | 2021 | 155 | 3.360 |
Why?
| Aortic Valve | 6 | 2021 | 208 | 2.390 |
Why?
| Mitral Valve Insufficiency | 6 | 2020 | 178 | 2.260 |
Why?
| Vascular Patency | 8 | 2020 | 125 | 1.850 |
Why?
| Pericardiectomy | 4 | 2020 | 9 | 1.850 |
Why?
| Treatment Outcome | 27 | 2022 | 7876 | 1.830 |
Why?
| Anastomosis, Surgical | 6 | 2020 | 298 | 1.730 |
Why?
| Heart Neoplasms | 3 | 2019 | 64 | 1.680 |
Why?
| Retrospective Studies | 24 | 2022 | 7595 | 1.650 |
Why?
| Aged | 35 | 2022 | 18477 | 1.490 |
Why?
| Humans | 75 | 2022 | 83011 | 1.460 |
Why?
| Coronary Angiography | 7 | 2020 | 234 | 1.320 |
Why?
| Myocardial Revascularization | 3 | 2021 | 34 | 1.310 |
Why?
| Middle Aged | 37 | 2021 | 25580 | 1.280 |
Why?
| Male | 46 | 2021 | 41827 | 1.250 |
Why?
| Length of Stay | 10 | 2020 | 696 | 1.230 |
Why?
| Obesity, Morbid | 2 | 2018 | 211 | 1.180 |
Why?
| Carbapenems | 2 | 2016 | 8 | 1.140 |
Why?
| Acinetobacter Infections | 2 | 2016 | 17 | 1.130 |
Why?
| beta-Lactam Resistance | 2 | 2016 | 17 | 1.130 |
Why?
| Thoracic Surgery | 2 | 2021 | 37 | 1.100 |
Why?
| Aortic Valve Stenosis | 3 | 2021 | 123 | 1.050 |
Why?
| Female | 37 | 2021 | 44686 | 0.980 |
Why?
| Atrial Fibrillation | 4 | 2020 | 267 | 0.970 |
Why?
| Fibroma | 2 | 2019 | 32 | 0.970 |
Why?
| Pulmonary Veins | 2 | 2020 | 66 | 0.970 |
Why?
| Heart Valve Diseases | 2 | 2019 | 103 | 0.940 |
Why?
| Reoperation | 3 | 2019 | 626 | 0.930 |
Why?
| Scimitar Syndrome | 1 | 2020 | 3 | 0.870 |
Why?
| Aged, 80 and over | 16 | 2019 | 6571 | 0.870 |
Why?
| Vena Cava, Superior | 1 | 2020 | 65 | 0.830 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2020 | 75 | 0.820 |
Why?
| Analgesia | 2 | 2021 | 56 | 0.820 |
Why?
| Anti-Bacterial Agents | 3 | 2016 | 812 | 0.820 |
Why?
| Cross Infection | 2 | 2012 | 192 | 0.820 |
Why?
| Pericarditis | 1 | 2019 | 14 | 0.810 |
Why?
| Mortality | 2 | 2018 | 148 | 0.810 |
Why?
| Physician Assistants | 1 | 2019 | 14 | 0.800 |
Why?
| Angioplasty, Balloon | 1 | 2019 | 96 | 0.780 |
Why?
| Mitral Valve Stenosis | 1 | 2019 | 42 | 0.770 |
Why?
| Blood Loss, Surgical | 1 | 2019 | 107 | 0.760 |
Why?
| Tricuspid Valve Insufficiency | 1 | 2020 | 99 | 0.760 |
Why?
| Aorta | 2 | 2019 | 301 | 0.760 |
Why?
| Blood Transfusion | 1 | 2019 | 152 | 0.730 |
Why?
| Surgery, Computer-Assisted | 2 | 2018 | 107 | 0.720 |
Why?
| Endovascular Procedures | 1 | 2020 | 170 | 0.720 |
Why?
| Aortic Valve Insufficiency | 1 | 2019 | 126 | 0.720 |
Why?
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.680 |
Why?
| Suture Techniques | 1 | 2018 | 140 | 0.670 |
Why?
| Mitral Valve | 5 | 2021 | 235 | 0.660 |
Why?
| Cardiopulmonary Bypass | 4 | 2020 | 166 | 0.660 |
Why?
| Acinetobacter baumannii | 1 | 2016 | 27 | 0.650 |
Why?
| Pericarditis, Constrictive | 1 | 2016 | 5 | 0.650 |
Why?
| Blood Vessel Prosthesis | 1 | 2018 | 230 | 0.630 |
Why?
| Equipment Design | 5 | 2018 | 421 | 0.630 |
Why?
| Hemorrhage | 1 | 2018 | 248 | 0.620 |
Why?
| beta-Lactamases | 1 | 2016 | 63 | 0.620 |
Why?
| Postoperative Complications | 5 | 2018 | 2266 | 0.620 |
Why?
| Bupivacaine | 1 | 2015 | 39 | 0.620 |
Why?
| Heart Ventricles | 2 | 2019 | 788 | 0.600 |
Why?
| Follow-Up Studies | 6 | 2020 | 3876 | 0.600 |
Why?
| Anesthetics, Local | 1 | 2015 | 80 | 0.590 |
Why?
| Heart Diseases | 1 | 2017 | 314 | 0.560 |
Why?
| Catheter Ablation | 2 | 2016 | 346 | 0.560 |
Why?
| Pain Management | 1 | 2015 | 128 | 0.550 |
Why?
| Risk Factors | 8 | 2021 | 5397 | 0.510 |
Why?
| Coronary Stenosis | 1 | 2013 | 47 | 0.500 |
Why?
| Postoperative Period | 3 | 2019 | 314 | 0.500 |
Why?
| Acinetobacter | 1 | 2012 | 4 | 0.490 |
Why?
| Klebsiella Infections | 1 | 2012 | 27 | 0.470 |
Why?
| Klebsiella pneumoniae | 1 | 2012 | 43 | 0.460 |
Why?
| Disease Outbreaks | 1 | 2012 | 189 | 0.430 |
Why?
| Echocardiography, Transesophageal | 4 | 2020 | 353 | 0.430 |
Why?
| Adult | 12 | 2021 | 25950 | 0.420 |
Why?
| Saudi Arabia | 3 | 2016 | 17 | 0.410 |
Why?
| Coronary Disease | 1 | 2011 | 308 | 0.400 |
Why?
| Tricuspid Valve | 2 | 2020 | 87 | 0.400 |
Why?
| Perioperative Period | 2 | 2019 | 28 | 0.390 |
Why?
| Cardiac Resynchronization Therapy | 2 | 2020 | 70 | 0.380 |
Why?
| Heart Failure | 1 | 2018 | 1084 | 0.380 |
Why?
| Heart Atria | 2 | 2016 | 248 | 0.370 |
Why?
| Combined Modality Therapy | 3 | 2018 | 1681 | 0.350 |
Why?
| Peripheral Vascular Diseases | 2 | 2018 | 60 | 0.350 |
Why?
| Prosthesis Design | 2 | 2019 | 304 | 0.340 |
Why?
| Stroke Volume | 2 | 2022 | 430 | 0.340 |
Why?
| Arrhythmias, Cardiac | 2 | 2020 | 202 | 0.340 |
Why?
| Pericardium | 2 | 2019 | 96 | 0.340 |
Why?
| Feasibility Studies | 2 | 2019 | 751 | 0.320 |
Why?
| Image Interpretation, Computer-Assisted | 3 | 2017 | 672 | 0.320 |
Why?
| Echocardiography, Three-Dimensional | 3 | 2017 | 506 | 0.320 |
Why?
| Ventricular Function, Left | 2 | 2022 | 581 | 0.310 |
Why?
| Hemodynamics | 2 | 2020 | 710 | 0.310 |
Why?
| Myocardial Infarction | 2 | 2019 | 370 | 0.300 |
Why?
| Chordae Tendineae | 2 | 2015 | 26 | 0.300 |
Why?
| Graft Occlusion, Vascular | 2 | 2019 | 101 | 0.280 |
Why?
| Analgesics, Opioid | 2 | 2021 | 372 | 0.280 |
Why?
| Endoscopes | 1 | 2004 | 15 | 0.280 |
Why?
| Surgical Stapling | 1 | 2004 | 19 | 0.280 |
Why?
| Microwaves | 1 | 2004 | 31 | 0.270 |
Why?
| Microbial Sensitivity Tests | 2 | 2016 | 218 | 0.270 |
Why?
| Hospital Mortality | 2 | 2019 | 322 | 0.270 |
Why?
| Cluster Analysis | 2 | 2016 | 373 | 0.260 |
Why?
| Patient Positioning | 2 | 2020 | 67 | 0.250 |
Why?
| Cardiovascular Diseases | 1 | 2009 | 812 | 0.230 |
Why?
| Pulmonary Edema | 1 | 2021 | 55 | 0.220 |
Why?
| Myocardial Bridging | 1 | 2020 | 1 | 0.220 |
Why?
| Prognosis | 2 | 2019 | 3698 | 0.220 |
Why?
| Time Factors | 3 | 2019 | 5497 | 0.220 |
Why?
| Morphine | 1 | 2021 | 136 | 0.220 |
Why?
| Lead Poisoning | 1 | 2020 | 8 | 0.220 |
Why?
| Nobel Prize | 1 | 2020 | 11 | 0.210 |
Why?
| Mitral Valve Prolapse | 1 | 2020 | 25 | 0.210 |
Why?
| Survival Analysis | 2 | 2017 | 1585 | 0.210 |
Why?
| Congenital Abnormalities | 1 | 2020 | 66 | 0.210 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 43 | 0.210 |
Why?
| Cardiac Resynchronization Therapy Devices | 1 | 2019 | 21 | 0.200 |
Why?
| Career Choice | 1 | 2021 | 139 | 0.200 |
Why?
| Multidetector Computed Tomography | 1 | 2020 | 57 | 0.200 |
Why?
| Epicardial Mapping | 1 | 2019 | 32 | 0.200 |
Why?
| Inservice Training | 1 | 2019 | 36 | 0.200 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 120 | 0.200 |
Why?
| Coronary Occlusion | 1 | 2019 | 8 | 0.200 |
Why?
| History, 21st Century | 1 | 2020 | 182 | 0.200 |
Why?
| Bioprosthesis | 1 | 2019 | 37 | 0.190 |
Why?
| Genotype | 2 | 2016 | 1853 | 0.190 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2019 | 67 | 0.190 |
Why?
| Safety | 1 | 2019 | 172 | 0.190 |
Why?
| Retreatment | 1 | 2018 | 106 | 0.190 |
Why?
| Young Adult | 3 | 2017 | 5959 | 0.190 |
Why?
| History, 20th Century | 1 | 2020 | 319 | 0.190 |
Why?
| Vascular Calcification | 1 | 2019 | 39 | 0.190 |
Why?
| Interactive Ventilatory Support | 1 | 2018 | 5 | 0.190 |
Why?
| Surgical Staplers | 1 | 2018 | 11 | 0.180 |
Why?
| Recovery of Function | 1 | 2019 | 265 | 0.180 |
Why?
| Mitral Valve Annuloplasty | 1 | 2017 | 18 | 0.180 |
Why?
| Radial Artery | 1 | 2017 | 27 | 0.180 |
Why?
| Saphenous Vein | 1 | 2017 | 66 | 0.180 |
Why?
| Heart Valve Prosthesis | 1 | 2018 | 95 | 0.170 |
Why?
| Morbidity | 1 | 2018 | 140 | 0.170 |
Why?
| Gender Identity | 1 | 2018 | 42 | 0.170 |
Why?
| Defibrillators, Implantable | 1 | 2019 | 157 | 0.170 |
Why?
| Acute Disease | 1 | 2019 | 864 | 0.170 |
Why?
| Renal Insufficiency | 1 | 2018 | 112 | 0.170 |
Why?
| Child, Preschool | 2 | 2016 | 3752 | 0.170 |
Why?
| Multilocus Sequence Typing | 1 | 2016 | 11 | 0.170 |
Why?
| Tissue and Organ Harvesting | 1 | 2017 | 80 | 0.170 |
Why?
| Atrial Septum | 1 | 2016 | 9 | 0.160 |
Why?
| Risk | 1 | 2018 | 700 | 0.160 |
Why?
| Prospective Studies | 2 | 2018 | 4065 | 0.160 |
Why?
| Cardiomyopathies | 1 | 2019 | 248 | 0.160 |
Why?
| Echocardiography | 2 | 2019 | 894 | 0.160 |
Why?
| Overweight | 1 | 2017 | 111 | 0.160 |
Why?
| Heart | 1 | 2020 | 526 | 0.160 |
Why?
| Severity of Illness Index | 2 | 2020 | 1777 | 0.160 |
Why?
| Molecular Epidemiology | 1 | 2016 | 59 | 0.160 |
Why?
| Coronary Sinus | 1 | 2016 | 7 | 0.160 |
Why?
| Quality Improvement | 1 | 2020 | 363 | 0.160 |
Why?
| Ventricular Fibrillation | 1 | 2016 | 73 | 0.160 |
Why?
| Recurrence | 1 | 2019 | 1193 | 0.160 |
Why?
| Prevalence | 2 | 2020 | 1261 | 0.160 |
Why?
| Plasmids | 1 | 2016 | 296 | 0.150 |
Why?
| Liposomes | 1 | 2015 | 104 | 0.150 |
Why?
| Hypertonic Solutions | 1 | 1995 | 17 | 0.150 |
Why?
| Cardiac Pacing, Artificial | 1 | 2016 | 105 | 0.150 |
Why?
| Anatomic Landmarks | 1 | 2015 | 34 | 0.150 |
Why?
| Organ Preservation Solutions | 1 | 1995 | 24 | 0.150 |
Why?
| DNA, Bacterial | 1 | 2016 | 271 | 0.150 |
Why?
| Heart Conduction System | 1 | 2016 | 153 | 0.150 |
Why?
| Heart Septal Defects, Atrial | 1 | 2015 | 64 | 0.150 |
Why?
| Pacemaker, Artificial | 1 | 2016 | 106 | 0.150 |
Why?
| Organ Preservation | 1 | 1995 | 63 | 0.150 |
Why?
| Therapeutics | 1 | 2014 | 11 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2017 | 347 | 0.140 |
Why?
| Tomography, X-Ray Computed | 4 | 2017 | 2568 | 0.140 |
Why?
| Intraoperative Complications | 1 | 2016 | 192 | 0.140 |
Why?
| Risk Assessment | 3 | 2021 | 2278 | 0.140 |
Why?
| Body Mass Index | 1 | 2018 | 783 | 0.140 |
Why?
| Device Removal | 1 | 2016 | 163 | 0.140 |
Why?
| Quality of Life | 1 | 2021 | 1357 | 0.140 |
Why?
| Comorbidity | 1 | 2017 | 937 | 0.130 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 996 | 0.130 |
Why?
| Pulmonary Artery | 1 | 1995 | 297 | 0.130 |
Why?
| Ischemia | 1 | 1995 | 244 | 0.130 |
Why?
| Child | 2 | 2016 | 6720 | 0.130 |
Why?
| Tachycardia, Ventricular | 1 | 2016 | 227 | 0.130 |
Why?
| Heart Arrest | 1 | 2016 | 262 | 0.130 |
Why?
| Heart Transplantation | 1 | 2018 | 662 | 0.120 |
Why?
| Case-Control Studies | 1 | 2017 | 1825 | 0.120 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 884 | 0.120 |
Why?
| Software | 1 | 2017 | 643 | 0.120 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 21 | 0.120 |
Why?
| Molecular Typing | 1 | 2012 | 15 | 0.120 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 50 | 0.120 |
Why?
| Wisconsin | 1 | 2011 | 42 | 0.120 |
Why?
| Heart-Assist Devices | 1 | 2019 | 668 | 0.120 |
Why?
| Intensive Care Units, Pediatric | 1 | 2012 | 93 | 0.110 |
Why?
| Cohort Studies | 2 | 2012 | 2704 | 0.110 |
Why?
| Radiography | 1 | 2013 | 873 | 0.110 |
Why?
| Adolescent | 2 | 2016 | 9117 | 0.110 |
Why?
| Burns | 1 | 2012 | 102 | 0.110 |
Why?
| Preoperative Care | 1 | 2013 | 419 | 0.110 |
Why?
| Hypertension | 1 | 2019 | 1207 | 0.110 |
Why?
| Obesity | 1 | 2017 | 965 | 0.100 |
Why?
| Reproducibility of Results | 4 | 2020 | 2665 | 0.100 |
Why?
| Infection Control | 1 | 2012 | 137 | 0.100 |
Why?
| Stroke | 1 | 2018 | 784 | 0.100 |
Why?
| Electrocardiography | 3 | 2019 | 579 | 0.100 |
Why?
| Odds Ratio | 1 | 2012 | 683 | 0.100 |
Why?
| Algorithms | 2 | 2017 | 1839 | 0.100 |
Why?
| Survival Rate | 2 | 2011 | 1918 | 0.100 |
Why?
| Lung | 1 | 1995 | 1058 | 0.100 |
Why?
| Angiography | 1 | 2009 | 212 | 0.090 |
Why?
| Intensive Care Units | 1 | 2012 | 370 | 0.090 |
Why?
| Myocardial Ischemia | 1 | 2009 | 166 | 0.090 |
Why?
| Image Enhancement | 3 | 2017 | 585 | 0.090 |
Why?
| Sensitivity and Specificity | 3 | 2017 | 2074 | 0.080 |
Why?
| Hospitalization | 1 | 2012 | 762 | 0.080 |
Why?
| Infant | 1 | 2012 | 3085 | 0.070 |
Why?
| Disease Progression | 1 | 2009 | 1469 | 0.070 |
Why?
| Equipment Failure Analysis | 1 | 2004 | 97 | 0.070 |
Why?
| Injections, Spinal | 1 | 2021 | 48 | 0.060 |
Why?
| Decontamination | 1 | 2021 | 9 | 0.060 |
Why?
| Myocardial Contraction | 1 | 2003 | 247 | 0.060 |
Why?
| Colombia | 1 | 2020 | 10 | 0.060 |
Why?
| Weights and Measures | 1 | 2020 | 8 | 0.050 |
Why?
| Perception | 1 | 2021 | 161 | 0.050 |
Why?
| Consensus | 1 | 2021 | 291 | 0.050 |
Why?
| Electrodes, Implanted | 1 | 2019 | 176 | 0.050 |
Why?
| Prosthesis Fitting | 1 | 2017 | 17 | 0.040 |
Why?
| Double-Blind Method | 1 | 2021 | 1899 | 0.040 |
Why?
| Sex Factors | 1 | 2020 | 1090 | 0.040 |
Why?
| Heart Injuries | 1 | 2016 | 17 | 0.040 |
Why?
| Vascular Surgical Procedures | 1 | 2017 | 159 | 0.040 |
Why?
| Pandemics | 1 | 2021 | 514 | 0.040 |
Why?
| Cerebrovascular Disorders | 1 | 1996 | 153 | 0.040 |
Why?
| Patient Selection | 1 | 2020 | 692 | 0.040 |
Why?
| Carotid Arteries | 1 | 1996 | 136 | 0.040 |
Why?
| Thromboxane B2 | 1 | 1995 | 15 | 0.040 |
Why?
| Surgical Wound Infection | 1 | 2017 | 181 | 0.040 |
Why?
| Raffinose | 1 | 1995 | 21 | 0.040 |
Why?
| Partial Pressure | 1 | 1995 | 52 | 0.040 |
Why?
| Indomethacin | 1 | 1995 | 62 | 0.040 |
Why?
| Imaging, Three-Dimensional | 1 | 2020 | 585 | 0.040 |
Why?
| Reperfusion | 1 | 1995 | 30 | 0.040 |
Why?
| Chronic Disease | 1 | 2019 | 964 | 0.040 |
Why?
| Vascular Resistance | 1 | 1995 | 106 | 0.040 |
Why?
| Glutathione | 1 | 1995 | 107 | 0.040 |
Why?
| Allopurinol | 1 | 1995 | 79 | 0.040 |
Why?
| Echocardiography, Doppler, Color | 1 | 2015 | 105 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1753 | 0.040 |
Why?
| Positron-Emission Tomography | 1 | 2016 | 272 | 0.040 |
Why?
| Clinical Competence | 1 | 2020 | 693 | 0.030 |
Why?
| Stomach | 1 | 2015 | 122 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2017 | 441 | 0.030 |
Why?
| Rabbits | 1 | 1995 | 716 | 0.030 |
Why?
| Observer Variation | 1 | 2015 | 621 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2017 | 856 | 0.030 |
Why?
| Adenosine | 1 | 1995 | 222 | 0.030 |
Why?
| Oxygen | 1 | 1995 | 718 | 0.030 |
Why?
| Insulin | 1 | 1995 | 1169 | 0.020 |
Why?
| Blood Pressure | 1 | 1995 | 1196 | 0.020 |
Why?
| Ultrasonography, Doppler | 1 | 1996 | 68 | 0.010 |
Why?
| Carotid Stenosis | 1 | 1996 | 105 | 0.010 |
Why?
| Animals | 1 | 1995 | 26931 | 0.010 |
Why?
| Multivariate Analysis | 1 | 1996 | 1011 | 0.010 |
Why?
|
|
Balkhy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|